AI platform identifies synergistic drug combination for resistant prostate cancer
A UCLA artificial intelligence platform paired with three-dimensional tumor testing identified berberine and enzalutamide as a synergistic combination in four ...
A UCLA artificial intelligence platform paired with three-dimensional tumor testing identified berberine and enzalutamide as a synergistic combination in four ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.